American Vietnamese Biotech Incorporation (HNX:AMV)

HNX:AMV Revenue

American Vietnamese Biotech Incorporation had revenue of 7.23B VND in the quarter ending March 31, 2026, a decrease of -88.62%. This brings the company's revenue in the last twelve months to 97.75B, down -70.20% year-over-year. In the year 2025, American Vietnamese Biotech Incorporation had annual revenue of 154.07B, down -50.36%.

• Revenue (ttm): 97.75B
• Revenue Growth: -70.20%
• P/S Ratio: 1.74
• Revenue / Employee: 948.98M
• Employees: 103
• Market Cap: 170.44B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	154.07B	-156.29B	-50.36%
Dec 31, 2024	310.35B	113.78B	57.88%
Dec 31, 2023	196.57B	-85.25B	-30.25%
Dec 31, 2022	281.82B	57.98B	25.90%
Dec 31, 2021	223.84B	62.41B	38.66%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 16, 2026

Data Sources Report a data error